2-((1-(1,4-dioxo-1,4-dihydronaphthalen-2-yl)-1H-1,2,3-triazol-4-yl)methylamino)naphthalene-1,4-dione

ID: ALA3114582

PubChem CID: 76317759

Max Phase: Preclinical

Molecular Formula: C23H14N4O4

Molecular Weight: 410.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1C=C(NCc2cn(C3=CC(=O)c4ccccc4C3=O)nn2)C(=O)c2ccccc21

Standard InChI:  InChI=1S/C23H14N4O4/c28-20-9-18(22(30)16-7-3-1-5-14(16)20)24-11-13-12-27(26-25-13)19-10-21(29)15-6-2-4-8-17(15)23(19)31/h1-10,12,24H,11H2

Standard InChI Key:  HANIQUTYFSDFSY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
    6.7304  -20.5781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3632  -17.9868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2783  -19.3389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8492  -18.5211    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.2633  -18.4788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4093  -19.3118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0780  -18.5665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8629  -21.8040    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4320  -19.6658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2594  -20.7204    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7316  -19.7590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9858  -19.7451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5692  -19.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4369  -20.9868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6906  -19.3345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7871  -19.1437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9280  -19.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5727  -20.5743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4351  -19.3505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6995  -18.7374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9779  -19.0593    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8606  -20.9873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1497  -20.5801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5674  -18.3544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5539  -17.9095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2197  -19.3968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1463  -19.7554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9304  -17.7342    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8538  -19.3378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7692  -18.5244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1194  -19.8897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 17  6  1  0
 16 31  2  0
 13  3  1  0
 19 11  1  0
 24 30  2  0
 31 17  1  0
  3 12  1  0
 25  7  1  0
 12 15  1  0
  7  5  1  0
 15  9  2  0
 27 29  1  0
  1 14  1  0
 30 15  1  0
 14 23  2  0
 17 10  2  0
 21 24  1  0
  7  6  2  0
  9 21  1  0
 16  5  1  0
  6 26  1  0
 22  8  2  0
 27 19  2  0
 13 29  1  0
  5 28  2  0
 18 13  2  0
 21 16  1  0
 20  2  1  0
 23 22  1  0
 29  4  2  0
  2 25  2  0
 26 20  2  0
 27 23  1  0
 11  1  2  0
 22 18  1  0
M  END

Associated Targets(Human)

PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MX1 (889 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

V79 (1637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L929 (3802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 410.39Molecular Weight (Monoisotopic): 410.1015AlogP: 2.25#Rotatable Bonds: 4
Polar Surface Area: 111.02Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 1.59CX LogD: 1.59
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.70Np Likeness Score: -0.21

References

1. da Cruz EH, Hussene CM, Dias GG, Diogo EB, de Melo IM, Rodrigues BL, da Silva MG, Valença WO, Camara CA, de Oliveira RN, de Paiva YG, Goulart MO, Cavalcanti BC, Pessoa C, da Silva Júnior EN..  (2014)  1,2,3-triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones.,  22  (5): [PMID:24530030] [10.1016/j.bmc.2014.01.033]

Source